Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial

Lancet Diabetes Endocrinol. 2023 Dec;11(12):894-895. doi: 10.1016/S2213-8587(23)00289-9.

Authors

Antonio Ceriello¹, Francesco Prattichizzo², Cesare Celeste Berra³, Augusto Enrique Caballero⁴

Affiliations

¹ IRCCS MultiMedica, Polo Scientifico e Tecnologico, 20138 Milan, Italy.
² IRCCS MultiMedica, Polo Scientifico e Tecnologico, 20138 Milan, Italy. Electronic address: [email protected].
³ IRCCS MultiMedica, Department of Diabetes, Milan, Italy.
⁴ Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

PMID: 37996193
DOI: 10.1016/S2213-8587(23)00289-9

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Glucose*
Humans
Hypoglycemic Agents / therapeutic use

Substances

Glucose
Hypoglycemic Agents